Analyst Ratings for CVS Caremark (CVS) [Buys]
CVS Rating Summary
CVS Price Target Summary
- Highest: $58.00 (Jefferies)
- Lowest: $38.50 (Deutsche Bank)
- Average: $50.55
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.55 (-14.5%)
Avg. $ Target:
$50.55 (-14.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/14/2012 | Macquarie | Upgrade | Outperform (Neutral) |
N/A (N/A) |
48.50 | 59.13 | 21.92% | Details |
| 8/15/2012 | Cantor Fitzgerald | New Coverage | Buy (N/A) |
55.00 (N/A) |
44.12 | 59.13 | 34.02% | Details |
| 8/8/2012 | BMO Capital | Upgrade | Outperform (Market Perform) |
53.00 (47.00) |
44.12 | 59.13 | 34.02% | Details |
| 7/17/2012 | JMP Securities | New Coverage | Market Outperform (N/A) |
55.00 (N/A) |
48.07 | 59.13 | 23.01% | Details |
| 7/12/2012 | ISI Group | New Coverage | Buy (N/A) |
53.50 (N/A) |
46.90 | 59.13 | 26.08% | Details |
| 11/7/2011 | RBC Capital | Upgrade | Outperform (N/A) |
44.00 (N/A) |
38.02 | 59.13 | 55.52% | Details |
| 11/4/2011 | Morgan Stanley | Upgrade | Overweight (N/A) |
N/A (N/A) |
37.15 | 59.13 | 59.17% | Details |
| 10/19/2011 | Mizuho Securities | New Coverage | Buy (N/A) |
39.00 (N/A) |
35.15 | 59.13 | 68.22% | Details |
| 7/26/2011 | William Blair | Upgrade | Outperform (N/A) |
N/A (N/A) |
37.06 | 59.13 | 59.55% | Details |
| 7/12/2011 | Dahlman Rose | New Coverage | Buy (N/A) |
N/A (N/A) |
37.44 | 59.13 | 57.93% | Details |
| 5/12/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
37.50 | 59.13 | 57.68% | Details |
